CA2979726A1 - Procede d'identification des recepteurs de lymphocytes t specifiques a compatibilite humaine pour une cible antigenique - Google Patents
Procede d'identification des recepteurs de lymphocytes t specifiques a compatibilite humaine pour une cible antigenique Download PDFInfo
- Publication number
- CA2979726A1 CA2979726A1 CA2979726A CA2979726A CA2979726A1 CA 2979726 A1 CA2979726 A1 CA 2979726A1 CA 2979726 A CA2979726 A CA 2979726A CA 2979726 A CA2979726 A CA 2979726A CA 2979726 A1 CA2979726 A1 CA 2979726A1
- Authority
- CA
- Canada
- Prior art keywords
- antigen
- cells
- sequence
- tcr
- subset
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108091008874 T cell receptors Proteins 0.000 title claims abstract description 189
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 title claims abstract description 187
- 238000000034 method Methods 0.000 title claims abstract description 106
- 230000000890 antigenic effect Effects 0.000 title abstract description 18
- 239000003814 drug Substances 0.000 claims abstract description 10
- 210000001744 T-lymphocyte Anatomy 0.000 claims description 116
- 239000000427 antigen Substances 0.000 claims description 106
- 108091007433 antigens Proteins 0.000 claims description 106
- 102000036639 antigens Human genes 0.000 claims description 106
- 210000004027 cell Anatomy 0.000 claims description 66
- 150000007523 nucleic acids Chemical class 0.000 claims description 51
- 102000039446 nucleic acids Human genes 0.000 claims description 41
- 108020004707 nucleic acids Proteins 0.000 claims description 41
- 230000008859 change Effects 0.000 claims description 20
- 210000004369 blood Anatomy 0.000 claims description 18
- 239000008280 blood Substances 0.000 claims description 18
- 230000001225 therapeutic effect Effects 0.000 claims description 16
- 238000000684 flow cytometry Methods 0.000 claims description 10
- BSDCIRGNJKZPFV-GWOFURMSSA-N (2r,3s,4r,5r)-2-(hydroxymethyl)-5-(2,5,6-trichlorobenzimidazol-1-yl)oxolane-3,4-diol Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=CC(Cl)=C(Cl)C=C2N=C1Cl BSDCIRGNJKZPFV-GWOFURMSSA-N 0.000 claims description 6
- 101000763322 Homo sapiens M1-specific T cell receptor beta chain Proteins 0.000 claims description 6
- 101000763321 Homo sapiens T cell receptor beta chain MC.7.G5 Proteins 0.000 claims description 6
- 102100026967 T cell receptor beta chain MC.7.G5 Human genes 0.000 claims description 6
- 101000634835 Homo sapiens M1-specific T cell receptor alpha chain Proteins 0.000 claims description 4
- 101000634836 Homo sapiens T cell receptor alpha chain MC.7.G5 Proteins 0.000 claims description 4
- 102100029454 T cell receptor alpha chain MC.7.G5 Human genes 0.000 claims description 4
- 201000010099 disease Diseases 0.000 abstract description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 7
- 239000013615 primer Substances 0.000 description 158
- 108091034117 Oligonucleotide Proteins 0.000 description 61
- 239000000523 sample Substances 0.000 description 61
- 238000012163 sequencing technique Methods 0.000 description 49
- 230000003044 adaptive effect Effects 0.000 description 45
- 230000003321 amplification Effects 0.000 description 44
- 238000003199 nucleic acid amplification method Methods 0.000 description 44
- 108091008915 immune receptors Proteins 0.000 description 43
- 125000003729 nucleotide group Chemical group 0.000 description 43
- 239000002773 nucleotide Substances 0.000 description 41
- 108090000765 processed proteins & peptides Proteins 0.000 description 41
- 102000027596 immune receptors Human genes 0.000 description 40
- 108020004414 DNA Proteins 0.000 description 39
- 238000003752 polymerase chain reaction Methods 0.000 description 38
- 238000006243 chemical reaction Methods 0.000 description 31
- 108090000623 proteins and genes Proteins 0.000 description 28
- 210000003719 b-lymphocyte Anatomy 0.000 description 27
- 230000000295 complement effect Effects 0.000 description 27
- 108091093088 Amplicon Proteins 0.000 description 26
- 108091028043 Nucleic acid sequence Proteins 0.000 description 26
- 210000004698 lymphocyte Anatomy 0.000 description 24
- 239000000203 mixture Substances 0.000 description 24
- 210000001519 tissue Anatomy 0.000 description 22
- 238000007403 mPCR Methods 0.000 description 21
- 101000946843 Homo sapiens T-cell surface glycoprotein CD8 alpha chain Proteins 0.000 description 18
- 102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 description 18
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 17
- 108091033319 polynucleotide Proteins 0.000 description 16
- 102000040430 polynucleotide Human genes 0.000 description 16
- 239000002157 polynucleotide Substances 0.000 description 16
- 101100112922 Candida albicans CDR3 gene Proteins 0.000 description 15
- 102000004196 processed proteins & peptides Human genes 0.000 description 15
- 206010028980 Neoplasm Diseases 0.000 description 14
- 230000008707 rearrangement Effects 0.000 description 14
- 230000002441 reversible effect Effects 0.000 description 14
- 238000004458 analytical method Methods 0.000 description 13
- 238000003556 assay Methods 0.000 description 13
- 238000009396 hybridization Methods 0.000 description 13
- 238000005259 measurement Methods 0.000 description 13
- 238000003753 real-time PCR Methods 0.000 description 13
- 229920001184 polypeptide Polymers 0.000 description 12
- 230000014509 gene expression Effects 0.000 description 11
- 108091008875 B cell receptors Proteins 0.000 description 10
- 241000894007 species Species 0.000 description 10
- 238000003786 synthesis reaction Methods 0.000 description 10
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 8
- 239000003155 DNA primer Substances 0.000 description 8
- 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 description 8
- 238000000137 annealing Methods 0.000 description 8
- 201000011510 cancer Diseases 0.000 description 8
- 238000007796 conventional method Methods 0.000 description 8
- 238000013459 approach Methods 0.000 description 7
- 239000011230 binding agent Substances 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 238000001514 detection method Methods 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 210000002865 immune cell Anatomy 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 108020004635 Complementary DNA Proteins 0.000 description 6
- -1 TCRG Proteins 0.000 description 6
- 238000010804 cDNA synthesis Methods 0.000 description 6
- 239000002299 complementary DNA Substances 0.000 description 6
- 108020004999 messenger RNA Proteins 0.000 description 6
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 6
- 238000010186 staining Methods 0.000 description 6
- 108091026890 Coding region Proteins 0.000 description 5
- 102000053602 DNA Human genes 0.000 description 5
- 108090000144 Human Proteins Proteins 0.000 description 5
- 102000003839 Human Proteins Human genes 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 238000005304 joining Methods 0.000 description 5
- 210000002751 lymph Anatomy 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 210000001266 CD8-positive T-lymphocyte Anatomy 0.000 description 4
- 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 description 4
- 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 description 4
- 108060003951 Immunoglobulin Proteins 0.000 description 4
- 102100026878 Interleukin-2 receptor subunit alpha Human genes 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 239000012472 biological sample Substances 0.000 description 4
- 239000007795 chemical reaction product Substances 0.000 description 4
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 4
- 210000004443 dendritic cell Anatomy 0.000 description 4
- 102000018358 immunoglobulin Human genes 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 210000005259 peripheral blood Anatomy 0.000 description 4
- 239000011886 peripheral blood Substances 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 102000005962 receptors Human genes 0.000 description 4
- 108020003175 receptors Proteins 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000013598 vector Substances 0.000 description 4
- 102100032937 CD40 ligand Human genes 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 101000868215 Homo sapiens CD40 ligand Proteins 0.000 description 3
- 101000599852 Homo sapiens Intercellular adhesion molecule 1 Proteins 0.000 description 3
- 101001018097 Homo sapiens L-selectin Proteins 0.000 description 3
- 101000851370 Homo sapiens Tumor necrosis factor receptor superfamily member 9 Proteins 0.000 description 3
- 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 3
- 102100033467 L-selectin Human genes 0.000 description 3
- 108010004729 Phycoerythrin Proteins 0.000 description 3
- 108010090804 Streptavidin Proteins 0.000 description 3
- 102100036856 Tumor necrosis factor receptor superfamily member 9 Human genes 0.000 description 3
- 102100022748 Wilms tumor protein Human genes 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 238000007792 addition Methods 0.000 description 3
- 108010004469 allophycocyanin Proteins 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 238000012165 high-throughput sequencing Methods 0.000 description 3
- 230000002998 immunogenetic effect Effects 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 238000000159 protein binding assay Methods 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 238000003757 reverse transcription PCR Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 108700028369 Alleles Proteins 0.000 description 2
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 2
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 description 2
- 108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 description 2
- 238000001712 DNA sequencing Methods 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 102000025850 HLA-A2 Antigen Human genes 0.000 description 2
- 108010074032 HLA-A2 Antigen Proteins 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 2
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 description 2
- 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 description 2
- 101000934346 Homo sapiens T-cell surface antigen CD2 Proteins 0.000 description 2
- 101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 description 2
- 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 2
- 241000725303 Human immunodeficiency virus Species 0.000 description 2
- 241000701806 Human papillomavirus Species 0.000 description 2
- 108700005091 Immunoglobulin Genes Proteins 0.000 description 2
- 108091092195 Intron Proteins 0.000 description 2
- 101150008942 J gene Proteins 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 description 2
- 241001529936 Murinae Species 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 102100025237 T-cell surface antigen CD2 Human genes 0.000 description 2
- 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 2
- 101150002618 TCRP gene Proteins 0.000 description 2
- 108091093126 WHP Posttrascriptional Response Element Proteins 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 239000013060 biological fluid Substances 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 229940072221 immunoglobulins Drugs 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 210000001165 lymph node Anatomy 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 238000007857 nested PCR Methods 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 210000003289 regulatory T cell Anatomy 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 238000012176 true single molecule sequencing Methods 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 238000011179 visual inspection Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 101150090724 3 gene Proteins 0.000 description 1
- 101100519158 Arabidopsis thaliana PCR2 gene Proteins 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 101100180402 Caenorhabditis elegans jun-1 gene Proteins 0.000 description 1
- 102100025570 Cancer/testis antigen 1 Human genes 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 108091033380 Coding strand Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 108010047041 Complementarity Determining Regions Proteins 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102100025137 Early activation antigen CD69 Human genes 0.000 description 1
- 238000011510 Elispot assay Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 241001125671 Eretmochelys imbricata Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108700024394 Exon Proteins 0.000 description 1
- 241000282324 Felis Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 101000856237 Homo sapiens Cancer/testis antigen 1 Proteins 0.000 description 1
- 101000934374 Homo sapiens Early activation antigen CD69 Proteins 0.000 description 1
- 101000622137 Homo sapiens P-selectin Proteins 0.000 description 1
- 101000801234 Homo sapiens Tumor necrosis factor receptor superfamily member 18 Proteins 0.000 description 1
- 101000679851 Homo sapiens Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 description 1
- 101150017040 I gene Proteins 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 108090000978 Interleukin-4 Proteins 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 241000713666 Lentivirus Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 108700018351 Major Histocompatibility Complex Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 108700011259 MicroRNAs Proteins 0.000 description 1
- 108020005196 Mitochondrial DNA Proteins 0.000 description 1
- 102100030569 Nuclear receptor corepressor 2 Human genes 0.000 description 1
- 101710153660 Nuclear receptor corepressor 2 Proteins 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 102100023472 P-selectin Human genes 0.000 description 1
- 239000012807 PCR reagent Substances 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 108091093037 Peptide nucleic acid Proteins 0.000 description 1
- 208000005228 Pericardial Effusion Diseases 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 101000757182 Saccharomyces cerevisiae Glucoamylase S2 Proteins 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 241000249107 Teschovirus A Species 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102100040247 Tumor necrosis factor Human genes 0.000 description 1
- 102100033728 Tumor necrosis factor receptor superfamily member 18 Human genes 0.000 description 1
- 102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 description 1
- 101150117115 V gene Proteins 0.000 description 1
- SWPYNTWPIAZGLT-UHFFFAOYSA-N [amino(ethoxy)phosphanyl]oxyethane Chemical compound CCOP(N)OCC SWPYNTWPIAZGLT-UHFFFAOYSA-N 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000033289 adaptive immune response Effects 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 230000030741 antigen processing and presentation Effects 0.000 description 1
- 210000000612 antigen-presenting cell Anatomy 0.000 description 1
- 238000002617 apheresis Methods 0.000 description 1
- 210000003567 ascitic fluid Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 238000007413 biotinylation Methods 0.000 description 1
- 230000006287 biotinylation Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 108700010039 chimeric receptor Proteins 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 239000003636 conditioned culture medium Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
- 238000004163 cytometry Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 1
- 229960002986 dinoprostone Drugs 0.000 description 1
- 238000005315 distribution function Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 210000003162 effector t lymphocyte Anatomy 0.000 description 1
- 230000012202 endocytosis Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000003114 enzyme-linked immunosorbent spot assay Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000012953 feeding on blood of other organism Effects 0.000 description 1
- 210000004700 fetal blood Anatomy 0.000 description 1
- 230000005669 field effect Effects 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000007672 fourth generation sequencing Methods 0.000 description 1
- 210000000609 ganglia Anatomy 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000002443 helper t lymphocyte Anatomy 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000005934 immune activation Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000009169 immunotherapy Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000009830 intercalation Methods 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000021633 leukocyte mediated immunity Effects 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 235000019689 luncheon sausage Nutrition 0.000 description 1
- 210000000207 lymphocyte subset Anatomy 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 210000003826 marginal zone b cell Anatomy 0.000 description 1
- 210000001806 memory b lymphocyte Anatomy 0.000 description 1
- 210000003071 memory t lymphocyte Anatomy 0.000 description 1
- 229920003087 methylethyl cellulose Polymers 0.000 description 1
- 239000002679 microRNA Substances 0.000 description 1
- 239000011325 microbead Substances 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000007799 mixed lymphocyte reaction assay Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 210000005087 mononuclear cell Anatomy 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 238000001668 nucleic acid synthesis Methods 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 201000003733 ovarian melanoma Diseases 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000004912 pericardial fluid Anatomy 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 150000004713 phosphodiesters Chemical class 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 210000004910 pleural fluid Anatomy 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 1
- 108020001580 protein domains Proteins 0.000 description 1
- 238000012175 pyrosequencing Methods 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 108020004418 ribosomal RNA Proteins 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 210000004911 serous fluid Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- 238000012384 transportation and delivery Methods 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/27—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterized by targeting or presenting multiple antigens
- A61K2239/28—Expressing multiple CARs, TCRs or antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/463—Cellular immunotherapy characterised by recombinant expression
- A61K39/4632—T-cell receptors [TCR]; antibody T-cell receptor constructs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
- A61K39/464452—Transcription factors, e.g. SOX or c-MYC
- A61K39/464453—Wilms tumor 1 [WT1]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6804—Nucleic acid analysis using immunogens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56977—HLA or MHC typing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
- G01N2333/7051—T-cell receptor (TcR)-CD3 complex
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
- G01N2333/70539—MHC-molecules, e.g. HLA-molecules
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
Abstract
L'invention concerne des procédés pour identifier des récepteurs de lymphocytes T qui se lient spécifiquement à une cible antigénique particulière, et peuvent être utilisés en tant qu'agents thérapeutiques contre une maladie.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562141701P | 2015-04-01 | 2015-04-01 | |
US62/141,701 | 2015-04-01 | ||
PCT/US2016/025535 WO2016161273A1 (fr) | 2015-04-01 | 2016-04-01 | Procédé d'identification des récepteurs de lymphocytes t spécifiques à compatibilité humaine pour une cible antigénique |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2979726A1 true CA2979726A1 (fr) | 2016-10-06 |
Family
ID=57006479
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2979726A Pending CA2979726A1 (fr) | 2015-04-01 | 2016-04-01 | Procede d'identification des recepteurs de lymphocytes t specifiques a compatibilite humaine pour une cible antigenique |
Country Status (5)
Country | Link |
---|---|
US (1) | US11041202B2 (fr) |
EP (1) | EP3277294B1 (fr) |
AU (1) | AU2016242967B2 (fr) |
CA (1) | CA2979726A1 (fr) |
WO (1) | WO2016161273A1 (fr) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2387627B1 (fr) | 2009-01-15 | 2016-03-30 | Adaptive Biotechnologies Corporation | Profilage d'immunité adaptative et méthodes de génération d'anticorps monoclonaux |
JP6302847B2 (ja) | 2012-03-05 | 2018-03-28 | アダプティヴ バイオテクノロジーズ コーポレーション | 頻度が一致したサブユニットからの、対をなす免疫受容体鎖の決定 |
JP5756247B1 (ja) | 2012-05-08 | 2015-07-29 | アダプティブ バイオテクノロジーズ コーポレイション | マルチプレックスpcr反応における増幅バイアスを測定し校正する組成物及び方法 |
US9708657B2 (en) | 2013-07-01 | 2017-07-18 | Adaptive Biotechnologies Corp. | Method for generating clonotype profiles using sequence tags |
US10066265B2 (en) | 2014-04-01 | 2018-09-04 | Adaptive Biotechnologies Corp. | Determining antigen-specific t-cells |
US11390921B2 (en) | 2014-04-01 | 2022-07-19 | Adaptive Biotechnologies Corporation | Determining WT-1 specific T cells and WT-1 specific T cell receptors (TCRs) |
EP3132059B1 (fr) | 2014-04-17 | 2020-01-08 | Adaptive Biotechnologies Corporation | Quantification de génomes de cellules de l'immunité acquise dans un mélange complexe de cellules |
AU2015339191A1 (en) | 2014-10-29 | 2017-05-18 | Adaptive Biotechnologies Corp. | Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from many samples |
US10246701B2 (en) | 2014-11-14 | 2019-04-02 | Adaptive Biotechnologies Corp. | Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture |
WO2016138122A1 (fr) | 2015-02-24 | 2016-09-01 | Adaptive Biotechnologies Corp. | Méthodes pour le diagnostic d'une maladie infectieuse et la détermination du statut hla à l'aide du séquençage du répertoire immunitaire |
CA2979726A1 (fr) | 2015-04-01 | 2016-10-06 | Adaptive Biotechnologies Corp. | Procede d'identification des recepteurs de lymphocytes t specifiques a compatibilite humaine pour une cible antigenique |
WO2017193104A1 (fr) | 2016-05-06 | 2017-11-09 | Fred Hutchinson Cancer Research Center | Immunothérapie de lymphocytes t spécifique de mart-1 |
US10428325B1 (en) | 2016-09-21 | 2019-10-01 | Adaptive Biotechnologies Corporation | Identification of antigen-specific B cell receptors |
US10550429B2 (en) | 2016-12-22 | 2020-02-04 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10815525B2 (en) | 2016-12-22 | 2020-10-27 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US11319590B2 (en) * | 2017-01-31 | 2022-05-03 | Ludwig Institute For Cancer Research Ltd. | Enhanced immune cell receptor sequencing methods |
CN110785432A (zh) * | 2017-04-24 | 2020-02-11 | 圣拉斐尔医院有限责任公司 | Tcr和肽 |
AU2018314242A1 (en) * | 2017-08-11 | 2020-02-13 | Fred Hutchinson Cancer Center | BRAF-specific TCRs and uses thereof |
WO2019055862A1 (fr) * | 2017-09-14 | 2019-03-21 | Fred Hutchinson Cancer Research Center | Récepteurs de lymphocytes t à haute affinité et leurs utilisations |
US11254980B1 (en) | 2017-11-29 | 2022-02-22 | Adaptive Biotechnologies Corporation | Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements |
SG11202007686VA (en) | 2018-02-12 | 2020-09-29 | 10X Genomics Inc | Methods characterizing multiple analytes from individual cells or cell populations |
MX2020008403A (es) | 2018-02-12 | 2020-09-25 | Hutchinson Fred Cancer Res | Receptores de celulas t especificos de ciclina a1 y usos de los mismos. |
WO2019217758A1 (fr) | 2018-05-10 | 2019-11-14 | 10X Genomics, Inc. | Procédés et systèmes de génération de banque moléculaire |
CN116298309B (zh) | 2018-08-13 | 2024-04-02 | 根路径基因组学公司 | 成对的二分免疫受体多核苷酸的高通量克隆及其应用 |
TW202031888A (zh) * | 2018-08-24 | 2020-09-01 | 日商組庫創世紀股份有限公司 | T細胞受體及b細胞受體之功能性次單元成對基因之解析方法 |
SG11202103571XA (en) * | 2018-10-16 | 2021-05-28 | Intellia Therapeutics Inc | Compositions and methods for immunotherapy |
SG11202110956RA (en) | 2019-04-05 | 2021-10-28 | Rootpath Genomics Inc | Compositions and methods for t-cell receptor gene assembly |
WO2021101956A1 (fr) * | 2019-11-19 | 2021-05-27 | Rootpath Genomics, Inc. | Compositions et procédés d'identification de récepteur de lymphocyte t |
US12112833B2 (en) | 2020-02-04 | 2024-10-08 | 10X Genomics, Inc. | Systems and methods for index hopping filtering |
US20230041268A1 (en) | 2021-03-24 | 2023-02-09 | Genentech, Inc. | Efficient tcr gene editing in t lymphocytes |
Family Cites Families (339)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
US5189147A (en) | 1984-06-13 | 1993-02-23 | Massachusetts Institute Of Technology | Meterodimeric T lymphocyte receptor antibody |
US4965188A (en) | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4800159A (en) | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
US4942124A (en) | 1987-08-11 | 1990-07-17 | President And Fellows Of Harvard College | Multiplex sequencing |
US5667967A (en) | 1990-05-01 | 1997-09-16 | The Board Of Trustees Of The Leland Stanford Junior University | T-cell receptor varible transcripts as disease related markers |
US5506126A (en) | 1988-02-25 | 1996-04-09 | The General Hospital Corporation | Rapid immunoselection cloning method |
US5168038A (en) | 1988-06-17 | 1992-12-01 | The Board Of Trustees Of The Leland Stanford Junior University | In situ transcription in cells and tissues |
JP2781438B2 (ja) | 1988-10-20 | 1998-07-30 | モーリィ,アリグザンダー,アラン | 白血病及びリンパ腫におけるモノクローナリテイーの診断法 |
US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
CA2020958C (fr) | 1989-07-11 | 2005-01-11 | Daniel L. Kacian | Methodes d'amplification de sequences d'acide nucleique |
US5298396A (en) | 1989-11-15 | 1994-03-29 | National Jewish Center For Immunology And Respiratory Medicine | Method for identifying T cells disease involved in autoimmune disease |
US5336598A (en) | 1989-11-15 | 1994-08-09 | National Jewish Center For Immunology And Respiratory Medicine | Method for diagnosing a superantigen caused pathologial condition via assay of T-cells |
US6916605B1 (en) | 1990-07-10 | 2005-07-12 | Medical Research Council | Methods for producing members of specific binding pairs |
EP0542810A1 (fr) | 1990-08-02 | 1993-05-26 | B.R. Centre Limited | Procedes de production de proteines presentant une fonction souhaitee |
US5210015A (en) | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
IE76732B1 (en) | 1990-08-07 | 1997-11-05 | Becton Dickinson Co | One step test for absolute counts |
US5635354A (en) | 1991-01-09 | 1997-06-03 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Method for describing the repertoires of antibodies (Ab) and of T-cell receptors (TcR) of an individual's immune system |
AU660306B2 (en) | 1991-02-12 | 1995-06-22 | Roussel-Uclaf | Nucleotidic sequences coding for variable regions of beta chains of human T lymphocyte receptors, corresponding peptidic segments and diagnostic and therapeutic applications |
JP3080178B2 (ja) | 1991-02-18 | 2000-08-21 | 東洋紡績株式会社 | 核酸配列の増幅方法およびそのための試薬キット |
US6091000A (en) | 1991-03-15 | 2000-07-18 | Duke University | SCID mouse engrafted with human synovium tissue |
US20040018489A1 (en) | 1991-09-09 | 2004-01-29 | Ma Wupo | Detection of RNA |
US5674679A (en) | 1991-09-27 | 1997-10-07 | Amersham Life Science, Inc. | DNA cycle sequencing |
US5213960A (en) | 1992-03-09 | 1993-05-25 | Tanox Biosystems, Inc. | Methods for selecting low frequency antigen-specific single B lymphocytes |
US5256542A (en) | 1992-03-09 | 1993-10-26 | Tanox Biosystems, Inc. | Selecting low frequency antigen-specific single B lymphocytes with correction for background noise |
US5837447A (en) | 1992-04-15 | 1998-11-17 | Blood Center Research Foundation, Inc., The | Monitoring an immune response by analysis of amplified immunoglobulin or T-cell-receptor nucleic acid |
US5981176A (en) | 1992-06-17 | 1999-11-09 | City Of Hope | Method of detecting and discriminating between nucleic acid sequences |
US5925517A (en) | 1993-11-12 | 1999-07-20 | The Public Health Research Institute Of The City Of New York, Inc. | Detectably labeled dual conformation oligonucleotide probes, assays and kits |
EP0753060A4 (fr) | 1994-04-18 | 1999-11-24 | New York Society | Sequences receptrices de lymphocytes t conservees |
FR2724182B1 (fr) | 1994-09-02 | 1996-12-13 | Pasteur Institut | Obtention d'un anticorps monoclonal recombinant a partir d'un anticorps monoclonal humain anti-rhesus d, sa production en cellules d'insecte, et ses utilisations |
US5604097A (en) | 1994-10-13 | 1997-02-18 | Spectragen, Inc. | Methods for sorting polynucleotides using oligonucleotide tags |
US5846719A (en) | 1994-10-13 | 1998-12-08 | Lynx Therapeutics, Inc. | Oligonucleotide tags for sorting and identification |
US5776737A (en) | 1994-12-22 | 1998-07-07 | Visible Genetics Inc. | Method and composition for internal identification of samples |
US6919434B1 (en) | 1995-02-20 | 2005-07-19 | Sankyo Co., Ltd. | Monoclonal antibodies that bind OCIF |
WO1997013868A1 (fr) | 1995-10-11 | 1997-04-17 | Leonard Adleman | Sequençage d'adn a grande echelle par une hybridation sensible a la position |
WO1997013877A1 (fr) | 1995-10-12 | 1997-04-17 | Lynx Therapeutics, Inc. | Mesure de profils d'expression genique pour evaluer la toxicite |
US6087096A (en) | 1995-11-13 | 2000-07-11 | Dau; Peter C. | Method of intrafamily fragment analysis of the T cell receptor α and β chain CDR3 regions |
US5854033A (en) | 1995-11-21 | 1998-12-29 | Yale University | Rolling circle replication reporter systems |
US20020076725A1 (en) | 1996-03-13 | 2002-06-20 | Tomoko Toyosaki-Maeda | Human t cell clone specific for rheumatoid arthritis |
US6458530B1 (en) | 1996-04-04 | 2002-10-01 | Affymetrix Inc. | Selecting tag nucleic acids |
US6416948B1 (en) | 1996-06-03 | 2002-07-09 | The Governors Of The University Of Alberta | Methods for detection of rearranged DNA |
NZ502323A (en) | 1996-06-04 | 2001-09-28 | Univ Utah Res Found | Monitoring a fluorescence energy transfer pair during hybridization of first probe labelled with fluorescein to second probe labelled with Cy5 or Cy5.5 |
AU3878697A (en) | 1996-06-20 | 1998-02-02 | Cornell Research Foundation Inc. | Identification of abnormalities in the expression of t and cell antigen receptors as indicators of disease diagnosis, prognosis and therapeutic predictors |
EP0937251B1 (fr) | 1996-09-06 | 2006-11-29 | Ortho-McNeil Pharmaceutical, Inc. | Purification de cellules t specifiques de l'antigene |
WO1998015644A2 (fr) | 1996-09-27 | 1998-04-16 | The Chinese University Of Hong Kong | Procede de sequencage en parallele de polynucleotides |
US6228589B1 (en) | 1996-10-11 | 2001-05-08 | Lynx Therapeutics, Inc. | Measurement of gene expression profiles in toxicity determination |
GB9626815D0 (en) | 1996-12-23 | 1997-02-12 | Cemu Bioteknik Ab | Method of sequencing DNA |
ES2563643T3 (es) | 1997-04-01 | 2016-03-15 | Illumina Cambridge Limited | Método de secuenciación de ácido nucleico |
PT1801214E (pt) | 1997-07-07 | 2011-01-20 | Medical Res Council | Método de triagem in vitro |
US7572582B2 (en) | 1997-09-12 | 2009-08-11 | Exiqon A/S | Oligonucleotide analogues |
WO1999019717A1 (fr) | 1997-10-15 | 1999-04-22 | Aclara Biosciences, Inc. | Dispositif a microstructure stratifiee et procede de fabrication de ce dispositif |
AU753732B2 (en) | 1997-10-23 | 2002-10-24 | Genzyme Corporation | Methods for detecting contamination in molecular diagnostics using PCR |
US7351578B2 (en) | 1999-12-10 | 2008-04-01 | Invitrogen Corp. | Use of multiple recombination sites with unique specificity in recombinational cloning |
JP4262799B2 (ja) | 1998-04-16 | 2009-05-13 | 平田機工株式会社 | 生タイヤ供給方法 |
DE19833738A1 (de) | 1998-07-27 | 2000-02-03 | Michael Giesing | Verfahren zur Isolierung von Krebszellen aus zellhaltigen Körperflüssigkeiten sowie Sets zur Durchführung dieses Verfahrens |
US6787308B2 (en) | 1998-07-30 | 2004-09-07 | Solexa Ltd. | Arrayed biomolecules and their use in sequencing |
AR021833A1 (es) | 1998-09-30 | 2002-08-07 | Applied Research Systems | Metodos de amplificacion y secuenciacion de acido nucleico |
DE19844931C1 (de) | 1998-09-30 | 2000-06-15 | Stefan Seeger | Verfahren zur DNS- oder RNS-Sequenzierung |
US6541608B1 (en) | 1999-02-23 | 2003-04-01 | Baylor College Of Medicine | T cell receptor Vβ-Dβ-Jβ sequence and methods for its detection |
US6300070B1 (en) | 1999-06-04 | 2001-10-09 | Mosaic Technologies, Inc. | Solid phase methods for amplifying multiple nucleic acids |
US6440706B1 (en) | 1999-08-02 | 2002-08-27 | Johns Hopkins University | Digital amplification |
ES2282133T3 (es) | 1999-08-24 | 2007-10-16 | Medarex, Inc. | Anticuerpos frente a la ctla-4 humano y sus usos. |
US20040209314A1 (en) | 1999-09-06 | 2004-10-21 | Institut National De La Sante Et De La Recherche Medicale France | Means for detection and purification of CD8+ T lymphocyte populations specific to peptides presented in the context of HLA |
US6235483B1 (en) | 2000-01-31 | 2001-05-22 | Agilent Technologies, Inc. | Methods and kits for indirect labeling of nucleic acids |
US20040121364A1 (en) | 2000-02-07 | 2004-06-24 | Mark Chee | Multiplex nucleic acid reactions |
US7955794B2 (en) | 2000-09-21 | 2011-06-07 | Illumina, Inc. | Multiplex nucleic acid reactions |
JP2004505612A (ja) | 2000-03-31 | 2004-02-26 | ユニバーシティ・オブ・サザン・カリフォルニア | 食道腺ガンに関する後成的配列 |
AUPQ687600A0 (en) | 2000-04-13 | 2000-05-11 | Flinders Technologies Pty Ltd | A method of detection |
US20030207300A1 (en) | 2000-04-28 | 2003-11-06 | Matray Tracy J. | Multiplex analytical platform using molecular tags |
US6596492B2 (en) | 2000-07-11 | 2003-07-22 | Colorado State University Research Foundation | PCR materials and methods useful to detect canine and feline lymphoid malignancies |
US7567870B1 (en) | 2000-07-31 | 2009-07-28 | Institute For Systems Biology | Multiparameter analysis for predictive medicine |
EP2044839A3 (fr) | 2000-08-03 | 2009-07-01 | Therapeutic Human Polyclonals, Inc. | Production d'anticorps humanisés chez des animaux transgéniques |
US6939451B2 (en) | 2000-09-19 | 2005-09-06 | Aclara Biosciences, Inc. | Microfluidic chip having integrated electrodes |
EP1366192B8 (fr) | 2000-10-24 | 2008-10-29 | The Board of Trustees of the Leland Stanford Junior University | Caracterisation multiplex directe d'adn genomique |
US6778724B2 (en) | 2000-11-28 | 2004-08-17 | The Regents Of The University Of California | Optical switching and sorting of biological samples and microparticles transported in a micro-fluidic device, including integrated bio-chip devices |
US6947748B2 (en) | 2000-12-15 | 2005-09-20 | Adaptix, Inc. | OFDMA with adaptive subcarrier-cluster configuration and selective loading |
WO2002066618A1 (fr) | 2001-02-20 | 2002-08-29 | University Of Georgia Research Foundation, Inc. | Production rapide d'anticorps monoclonaux |
US7265208B2 (en) | 2001-05-01 | 2007-09-04 | The Regents Of The University Of California | Fusion molecules and treatment of IgE-mediated allergic diseases |
US20040235061A1 (en) | 2001-05-24 | 2004-11-25 | Wilkie Bruce N. | Methods for selecting and producing animals having a predicted level of immune response, disease resistance or susceptibility, and/or productivity |
US20050260570A1 (en) | 2001-05-29 | 2005-11-24 | Mao Jen-I | Sequencing by proxy |
US7026121B1 (en) | 2001-06-08 | 2006-04-11 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
US6720144B1 (en) | 2001-06-21 | 2004-04-13 | Quest Diagnostics | Detection of clonal T-cell receptor-γ gene rearrangement by PCR/temporal temperature gradient gel electrophoresis (TTGE) |
US7112423B2 (en) | 2001-07-15 | 2006-09-26 | Keck Graduate Institute | Nucleic acid amplification using nicking agents |
US20030096277A1 (en) | 2001-08-30 | 2003-05-22 | Xiangning Chen | Allele specific PCR for genotyping |
AU2002322518A1 (en) | 2001-08-31 | 2003-03-18 | Rosetta Inpharmactis Llc | Methods for preparing nucleic acid samples |
WO2003020763A2 (fr) | 2001-08-31 | 2003-03-13 | Avidex Limited | Substances |
CA2460639C (fr) | 2001-09-19 | 2013-07-16 | Alexion Pharmaceuticals, Inc. | Matrices transgeniques et leurs utilisations dans l'amplification d'amorce unique |
CA2466502A1 (fr) | 2001-11-09 | 2003-05-15 | Source Precision Medicine, Inc. | Identification, surveillance et traitement d'une maladie et definition d'un etat biologique a l'aide de profils d'expression genetique |
GB2382137A (en) | 2001-11-20 | 2003-05-21 | Mats Gullberg | Nucleic acid enrichment |
GB0128153D0 (en) | 2001-11-23 | 2002-01-16 | Bayer Ag | Profiling of the immune gene repertoire |
WO2003052101A1 (fr) | 2001-12-14 | 2003-06-26 | Rosetta Inpharmatics, Inc. | Suivi des echantillons au moyen du code barres moleculaire |
GB0130267D0 (en) | 2001-12-19 | 2002-02-06 | Neutec Pharma Plc | Focussed antibody technology |
AU2003207528A1 (en) | 2002-01-09 | 2003-07-30 | Maxx Genetech Co. Ltd | Method of detecting t-cell proliferation for diagnosis of diseases by gene array |
US7323306B2 (en) | 2002-04-01 | 2008-01-29 | Brookhaven Science Associates, Llc | Genome signature tags |
US7157274B2 (en) | 2002-06-24 | 2007-01-02 | Cytonome, Inc. | Method and apparatus for sorting particles |
JP2006503587A (ja) | 2002-05-16 | 2006-02-02 | バンダービルト・ユニバーシティ | 自己免疫疾患の予測方法 |
EP1573636A2 (fr) | 2002-07-01 | 2005-09-14 | Institut Pasteur | Systeme, procede, dispositif et progiciel permettant d'extraire, de rassembler, de manipuler et d'analyser des donnees de crete d'un sequenceur automatique |
CA2490903A1 (fr) | 2002-07-03 | 2004-01-15 | Institute For Scientific Research, Inc. | Compositions et procedes de detection de l'expression de genes d'une famille variable de recepteurs de lymphocytes t humains |
JP5068931B2 (ja) | 2002-07-12 | 2012-11-07 | ザ ジョンズ ホプキンス ユニバーシティー | 独自のクローン形質のリンパ球受容体に結合する試薬および方法 |
US7476519B2 (en) | 2002-07-19 | 2009-01-13 | Joseph Monforte | Strategies for gene expression analysis |
US7157228B2 (en) | 2002-09-09 | 2007-01-02 | Bioarray Solutions Ltd. | Genetic analysis and authentication |
US7459273B2 (en) | 2002-10-04 | 2008-12-02 | Affymetrix, Inc. | Methods for genotyping selected polymorphism |
ATE483822T1 (de) | 2002-10-11 | 2010-10-15 | Univ Erasmus | Primer für nukleinsäureamplifikation in pcr- basierten klonalitätsstudien |
EP1597557A4 (fr) | 2002-10-11 | 2008-06-11 | Univ California | Methode permettant de diagnostiquer et de pronostiquer la sclerose en plaques |
WO2004044209A1 (fr) | 2002-11-13 | 2004-05-27 | Monoquant Pty Ltd | Methode de detection |
DK1566635T3 (da) | 2002-11-14 | 2012-03-19 | Vivalis | Chip med array af mikrobrønde til påvisning af antigenspecifik lymfocyt, fremgangsmåde til påvisning af antigenspecifik lymfocyt og fremgangsmåde til kloning af antigenspecifik lymfocyt-antigenreceptorgen |
JP2006512927A (ja) | 2002-12-11 | 2006-04-20 | コーリー ファーマシューティカル グループ,インコーポレイテッド | 5’cpg核酸およびその使用方法 |
WO2004063706A2 (fr) | 2003-01-08 | 2004-07-29 | Maxx Genetech Co., Ltd. | Procede permettant de detecter la surexpression des genes du recepteur des lymphocytes t par pcr en temps reel |
ES2396245T3 (es) | 2003-01-29 | 2013-02-20 | 454 Life Sciences Corporation | Método de amplificación y secuenciamiento de ácidos nucleicos |
GB0304068D0 (en) | 2003-02-22 | 2003-03-26 | Avidex Ltd | Substances |
US20070042349A1 (en) | 2003-04-24 | 2007-02-22 | Ogle Brenda M | Methods for assessing biologic diversity |
AU2003902299A0 (en) | 2003-05-13 | 2003-05-29 | Flinders Medical Centre | A method of analysing a marker nucleic acid molecule |
US20070105105A1 (en) | 2003-05-23 | 2007-05-10 | Mount Sinai School Of Medicine Of New York University | Surrogate cell gene expression signatures for evaluating the physical state of a subject |
US20050010030A1 (en) | 2003-07-02 | 2005-01-13 | Zang Jingwu Z. | T cell receptor CDR3 sequence and methods for detecting and treating rheumatoid arthritis |
WO2005010145A2 (fr) | 2003-07-05 | 2005-02-03 | The Johns Hopkins University | Procede et compositions de detection et d'enumeration de variations genetiques |
TW200510723A (en) | 2003-07-15 | 2005-03-16 | Bioarray Solutions Ltd | Concurrent optimization in selection of primer and capture probe sets for nucleic acid analysis |
US20060228350A1 (en) | 2003-08-18 | 2006-10-12 | Medimmune, Inc. | Framework-shuffling of antibodies |
US20050048498A1 (en) | 2003-08-29 | 2005-03-03 | Applera Corporation | Compositions, methods, and kits for assembling probes |
WO2005026686A2 (fr) | 2003-09-09 | 2005-03-24 | Compass Genetics, Llc | Plate-forme analytique multiplexee |
TWI333977B (en) | 2003-09-18 | 2010-12-01 | Symphogen As | Method for linking sequences of interest |
FR2863274B1 (fr) | 2003-12-05 | 2012-11-16 | Commissariat Energie Atomique | Procede d'evaluation quantitative d'un rearrangement ou d'une recombinaison genetique ciblee d'un individu et ses applications. |
US20070238099A1 (en) | 2003-12-08 | 2007-10-11 | Cohen Irun R | Antigen Receptor Variable Region Typing |
US20080166718A1 (en) | 2003-12-15 | 2008-07-10 | Institut Pasteur | Repertoire determination of a lymphocyte B population |
WO2005059176A1 (fr) | 2003-12-15 | 2005-06-30 | Institut Pasteur | Determination du repertoire d'une population de lymphocytes b |
ATE421998T1 (de) | 2003-12-15 | 2009-02-15 | Pasteur Institut | Ermittlung des repertoires von b-lymphozyten populationen |
CA2556981C (fr) | 2004-02-18 | 2015-10-13 | The Trustees Of Boston University | Procede pour detecter et quantifier des mutations ou polymorphismes rares |
US20060046258A1 (en) | 2004-02-27 | 2006-03-02 | Lapidus Stanley N | Applications of single molecule sequencing |
US20070161001A1 (en) | 2004-03-04 | 2007-07-12 | Dena Leshkowitz | Quantifying and profiling antibody and t cell receptor gene expression |
JP4480423B2 (ja) | 2004-03-08 | 2010-06-16 | 独立行政法人科学技術振興機構 | 免疫細胞クローンの拡大の有無の判定方法 |
DE102004016437A1 (de) | 2004-04-04 | 2005-10-20 | Oligene Gmbh | Verfahren zur Erkennung von Signaturen in komplexen Genexpressionsprofilen |
US20050250147A1 (en) | 2004-05-10 | 2005-11-10 | Macevicz Stephen C | Digital profiling of polynucleotide populations |
JP2007536939A (ja) | 2004-05-14 | 2007-12-20 | アモークス インコーポレーティッド | 免疫細胞バイオセンサーおよびその使用方法 |
EP1598429A1 (fr) | 2004-05-19 | 2005-11-23 | Amplion Ltd. | Détection des contaminations par des amplicons lors de PCR présentant deux températures différentes d'appariement |
GB0412973D0 (en) | 2004-06-10 | 2004-07-14 | Celltech R&D Ltd | Identification of antibody producing cells |
US20060020397A1 (en) | 2004-07-21 | 2006-01-26 | Kermani Bahram G | Methods for nucleic acid and polypeptide similarity search employing content addressable memories |
US20060019304A1 (en) | 2004-07-26 | 2006-01-26 | Paul Hardenbol | Simultaneous analysis of multiple genomes |
US7820382B2 (en) | 2004-08-03 | 2010-10-26 | Bauer A Robert | Method for the early detection of breast cancer, lung cancer, pancreatic cancer and colon polyps, growths and cancers as well as other gastrointestinal disease conditions and the preoperative and postoperative monitoring of transplanted organs from the donor and in the recipient and their associated conditions related and unrelated to the organ transplantation |
US20060094018A1 (en) | 2004-08-03 | 2006-05-04 | Bauer A R Jr | Discovery and a method for the early detection of pancreatic cancer and other disease conditions |
PL1773885T3 (pl) | 2004-08-05 | 2010-09-30 | Genentech Inc | Humanizowani antagoniści anty c-met |
WO2006031221A1 (fr) | 2004-09-13 | 2006-03-23 | Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Préparations comprenant des récepteurs cellulaires t et méthodes d'utilisation de ces préparations |
US7170050B2 (en) | 2004-09-17 | 2007-01-30 | Pacific Biosciences Of California, Inc. | Apparatus and methods for optical analysis of molecules |
WO2006050138A2 (fr) | 2004-10-29 | 2006-05-11 | Benaroya Research Institute At Virginia Mason | Methodes de generation de cellules t de regulation cd4+cd25+ specifiques a un antigene, compositions et methodes d'utilisation associees |
US7966988B2 (en) | 2005-01-11 | 2011-06-28 | Exxonmobil Research And Engineering Company | Method for controlling soot induced lubricant viscosity increase |
US8029783B2 (en) | 2005-02-02 | 2011-10-04 | Genentech, Inc. | DR5 antibodies and articles of manufacture containing same |
FR2881436B1 (fr) | 2005-02-03 | 2007-04-27 | Commissariat Energie Atomique | Procede de determination de la diversite des lymphocytes t dans un echantillon biologique |
US7393665B2 (en) | 2005-02-10 | 2008-07-01 | Population Genetics Technologies Ltd | Methods and compositions for tagging and identifying polynucleotides |
WO2006089233A2 (fr) | 2005-02-16 | 2006-08-24 | Wyeth | Methodes et systemes de diagnostic, de pronostic et de selection du traitement d'une leucemie |
US7537894B2 (en) | 2005-03-02 | 2009-05-26 | The University Of Chicago | Methods and kits for monitoring Barrett's metaplasia |
US20060216737A1 (en) | 2005-03-10 | 2006-09-28 | John Bodeau | Methods for multiplex amplification |
WO2006099604A2 (fr) | 2005-03-16 | 2006-09-21 | Compass Genetics, Llc | Procedes et compositions pour releves de mesures sur de multiples plate-formes analytiques |
JP2008538496A (ja) | 2005-04-12 | 2008-10-30 | 454 ライフ サイエンシーズ コーポレイション | ウルトラディープ配列決定を用いて配列変異体を決定するための方法 |
WO2006116155A2 (fr) | 2005-04-21 | 2006-11-02 | The Regents Of The University Of California | Methode de diagnostic et de pronostic de sous-types de sclerose en plaques |
US20060263789A1 (en) | 2005-05-19 | 2006-11-23 | Robert Kincaid | Unique identifiers for indicating properties associated with entities to which they are attached, and methods for using |
US7208795B2 (en) | 2005-05-24 | 2007-04-24 | Atmel Corporation | Low-cost, low-voltage single-layer polycrystalline EEPROM memory cell integration into BiCMOS technology |
EP3257949A1 (fr) | 2005-06-15 | 2017-12-20 | Complete Genomics Inc. | Analyse d'acide nucléique par des mélanges aléatoires de fragments non chevauchants |
US20070020670A1 (en) | 2005-07-07 | 2007-01-25 | Hematologics, Inc. | Methods for detecting and confirming minimal disease |
US20070020640A1 (en) | 2005-07-21 | 2007-01-25 | Mccloskey Megan L | Molecular encoding of nucleic acid templates for PCR and other forms of sequence analysis |
GB0521521D0 (en) | 2005-10-21 | 2005-11-30 | Medical Res Council | Diagnostic methods and kits |
GB0522310D0 (en) | 2005-11-01 | 2005-12-07 | Solexa Ltd | Methods of preparing libraries of template polynucleotides |
US20070105165A1 (en) | 2005-11-04 | 2007-05-10 | Charles Goolsby | Composite profiles of cell antigens and target signal transduction proteins for analysis and clinical management of hematologic cancers |
US7375211B2 (en) | 2005-11-18 | 2008-05-20 | Kou Zhong C | Method for detection and quantification of T-cell receptor Vβ repertoire |
US8137936B2 (en) | 2005-11-29 | 2012-03-20 | Macevicz Stephen C | Selected amplification of polynucleotides |
US7544473B2 (en) | 2006-01-23 | 2009-06-09 | Population Genetics Technologies Ltd. | Nucleic acid analysis using sequence tokens |
US7537897B2 (en) | 2006-01-23 | 2009-05-26 | Population Genetics Technologies, Ltd. | Molecular counting |
SG170028A1 (en) | 2006-02-24 | 2011-04-29 | Callida Genomics Inc | High throughput genome sequencing on dna arrays |
MX2008011280A (es) | 2006-03-06 | 2008-09-12 | Symphogen As | Anticuerpor policlonal recombinante para el tratamiento de infecciones por el virus sincitial respiratorio. |
ES2546848T3 (es) | 2006-03-10 | 2015-09-29 | Epigenomics Ag | Un método para identificar una muestra biológica para el análisis de la metilación |
WO2007114693A2 (fr) | 2006-04-04 | 2007-10-11 | Keygene N.V. | Detection de marqueurs moleculaires a haut rendement base sur des fragments de restriction |
CA2652086A1 (fr) | 2006-05-11 | 2007-11-22 | University Of Maryland Biotechnology Institute | Procede general permettant de generer in vitro des reponses d'anticorps humains |
WO2007136518A2 (fr) | 2006-05-17 | 2007-11-29 | Torrey Pines Institute For Molecular Studies | Traitement de troubles auto-immunitaires |
CA2653256C (fr) | 2006-05-25 | 2018-08-28 | Institute For Advanced Study | Methodes d'identification de motifs de sequence et applications associees |
US7833716B2 (en) | 2006-06-06 | 2010-11-16 | Gen-Probe Incorporated | Tagged oligonucleotides and their use in nucleic acid amplification methods |
AU2007261114B2 (en) | 2006-06-12 | 2012-07-12 | Pacific Biosciences Of California, Inc. | Substrates for performing analytical reactions |
US8372584B2 (en) | 2006-06-14 | 2013-02-12 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US20100027896A1 (en) | 2006-06-28 | 2010-02-04 | Amir Geva | Automated application interaction using a virtual operator |
US7553949B2 (en) | 2006-06-30 | 2009-06-30 | Applied Biosystems, Llc | Reversible terminator nucleotides and methods of use |
WO2008108803A2 (fr) | 2006-07-13 | 2008-09-12 | Amaox, Ltd. | Biocapteurs de cellules immunitaires et méthodes d'utilisation correspondantes |
US8394590B2 (en) | 2006-08-02 | 2013-03-12 | California Institute Of Technology | Capture agents and related methods and systems for detecting and/or sorting targets |
US20080274904A1 (en) | 2006-08-10 | 2008-11-06 | Niall Anthony Gormley | Method of target enrichment |
WO2008026927A2 (fr) | 2006-08-30 | 2008-03-06 | Academisch Medisch Centrum | Procédé d'affichage des répertoires des récepteurs des lymphocytes t et b |
WO2008039694A2 (fr) | 2006-09-26 | 2008-04-03 | St. Jude Children's Research Hospital | Procédés et compositions de surveillance de la diversité des récepteurs des lymphocytes t |
US8088379B2 (en) | 2006-09-26 | 2012-01-03 | The United States Of America As Represented By The Department Of Health And Human Services | Modified T cell receptors and related materials and methods |
JP5026047B2 (ja) | 2006-10-18 | 2012-09-12 | 株式会社膠原病研究所 | 自己免疫疾患の発症に関わる自己応答性t細胞またはt細胞受容体の同定方法、およびその利用 |
WO2008140484A2 (fr) | 2006-11-09 | 2008-11-20 | Xdx, Inc. | Procédés pour diagnostiquer et surveiller l'état d'un lupus érythémateux systémique |
US8262900B2 (en) | 2006-12-14 | 2012-09-11 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
US7862999B2 (en) | 2007-01-17 | 2011-01-04 | Affymetrix, Inc. | Multiplex targeted amplification using flap nuclease |
EP2121983A2 (fr) | 2007-02-02 | 2009-11-25 | Illumina Cambridge Limited | Procedes pour indexer des echantillons et sequencer de multiples matrices nucleotidiques |
DK2121920T3 (da) | 2007-03-01 | 2011-11-21 | Symphogen As | Fremgangsmåde til kloning af sammenhørende antistoffer |
WO2008147879A1 (fr) | 2007-05-22 | 2008-12-04 | Ryan Golhar | Procede et dispositif automatises d'identification et d'isolement d'adn et de definition de sequences |
CA2689356A1 (fr) | 2007-06-01 | 2008-12-11 | 454 Life Sciences Corporation | Systeme et procede d'identification d'echantillons individuels a partir d'un melange multiplex |
WO2009015296A1 (fr) | 2007-07-24 | 2009-01-29 | The Regents Of The University Of California | Générateur de gouttelettes microfabriqué |
JP2010534474A (ja) | 2007-07-26 | 2010-11-11 | パシフィック バイオサイエンシーズ オブ カリフォルニア, インコーポレイテッド | 分子冗長配列決定 |
ITRM20070429A1 (it) | 2007-08-06 | 2009-02-07 | Uni Cattolica Del Sacro Cuor E | Mezzi per la diagnosi la prevenzione e la cura dell'artrite reumatoide. |
JP5547071B2 (ja) | 2007-08-09 | 2014-07-09 | セルラ・インコーポレイテッド | 関連付け多パラメーター単一細胞測定および残留する生物学的材料の回収のための方法および装置 |
US8268564B2 (en) | 2007-09-26 | 2012-09-18 | President And Fellows Of Harvard College | Methods and applications for stitched DNA barcodes |
WO2009045898A2 (fr) | 2007-09-28 | 2009-04-09 | Mayo Foundation For Medical Education And Research | Évaluation de répertoires de lymphocytes t |
US7960116B2 (en) | 2007-09-28 | 2011-06-14 | Pacific Biosciences Of California, Inc. | Nucleic acid sequencing methods and systems |
AU2008323701B2 (en) | 2007-11-07 | 2015-03-26 | Genentech, Inc | Methods and compositions for assessing responsiveness of B-cell lymphoma to treatment with anti-CD40 antibodies |
EP2060637A1 (fr) | 2007-11-14 | 2009-05-20 | Koninklijke Philips Electronics N.V. | Supports et procédé de détection d'acides nucléiques |
WO2009070767A2 (fr) | 2007-11-28 | 2009-06-04 | Whitehead Institute For Biomedical Research | Systèmes de promotion systémique pour étudier la croissance ou métastase d'une tumeur |
EP2062982A1 (fr) | 2007-11-26 | 2009-05-27 | ImmunID | Procédé d'étude de la diversité combinatoire V(D)J |
CN101225441B (zh) | 2007-12-05 | 2010-12-01 | 浙江大学 | 一种检测克隆特异性t淋巴细胞tcr bv cdr3基因组成的方法 |
US20100021894A1 (en) | 2007-12-20 | 2010-01-28 | Northwestern University | Nanoparticle-Based Colorimetric Detection Of Cysteine |
US8621502B2 (en) | 2007-12-21 | 2013-12-31 | Microsoft Corporation | Obtaining user reactions to video |
US7767400B2 (en) | 2008-02-03 | 2010-08-03 | Helicos Biosciences Corporation | Paired-end reads in sequencing by synthesis |
EP2088432A1 (fr) | 2008-02-11 | 2009-08-12 | MorphoSys AG | Procédés pour l'identification d'un anticorps ou d'une cible |
WO2009108860A2 (fr) | 2008-02-28 | 2009-09-03 | The Ohio University Rasearch Foundation | Procédés et compositions à base de micro-arn permettant de diagnostiquer, de pronostiquer et de traiter des troubles liés à la prostate |
EP2250496A4 (fr) | 2008-02-28 | 2011-08-31 | Univ Ohio State Res Found | Signatures en micro-arn associées à la cytogénétique et au pronostic dans la leucémie myéloïde aiguë (aml) et leurs utilisations |
US20090226975A1 (en) | 2008-03-10 | 2009-09-10 | Illumina, Inc. | Constant cluster seeding |
TW200938840A (en) | 2008-03-12 | 2009-09-16 | Emo Biomedicine Corp | A method for in vitro study of immune modulation using pig blood cell |
US8143007B2 (en) | 2008-03-13 | 2012-03-27 | National Institute Of Immunology | Nested primer sets for amplifying mouse immunoglobulin variable gene segments |
BRPI0909212A2 (pt) | 2008-03-28 | 2015-08-18 | Pacific Biosciences California | Composições e método para sequeciamento de ácido nucléico |
ATE530497T1 (de) | 2008-03-31 | 2011-11-15 | Sony Deutschland Gmbh | Verfahren zur herstellung einer membran mit konischer pore |
ES2549184T3 (es) | 2008-04-16 | 2015-10-23 | Cb Biotechnologies, Inc. | Método para evaluar y comparar inmunorepertorios |
US8911948B2 (en) | 2008-04-30 | 2014-12-16 | Integrated Dna Technologies, Inc. | RNase H-based assays utilizing modified RNA monomers |
CA2725548A1 (fr) | 2008-05-09 | 2009-11-12 | Duke University | Auto-anticorps dans la detection et le traitement du cancer |
US9068181B2 (en) | 2008-05-23 | 2015-06-30 | The General Hospital Corporation | Microfluidic droplet encapsulation |
DE102008025656B4 (de) | 2008-05-28 | 2016-07-28 | Genxpro Gmbh | Verfahren zur quantitativen Analyse von Nukleinsäuren, Marker dafür und deren Verwendung |
CN102112624A (zh) | 2008-05-30 | 2011-06-29 | 麻省理工学院 | 用于对细胞进行空间分割以及筛选的组合物以及方法 |
WO2009151628A2 (fr) | 2008-06-12 | 2009-12-17 | Gov't Of The Usa, As Represented By The Secretary, Department Of Health Human Services | Surveillance de tcr-b en vue de déterminer une thérapie de vih et l'évolution d'une maladie |
KR20110036590A (ko) | 2008-06-25 | 2011-04-07 | 베일러 리서치 인스티튜트 | 결핵균 감염의 혈액 전사 시그너처 |
US8394583B2 (en) | 2008-07-24 | 2013-03-12 | The Board Of Regents Of The University Of Texas System | VH4 codon signature for multiple sclerosis |
ES2752025T3 (es) | 2008-07-25 | 2020-04-02 | Wagner Richard W | Métodos de cribado de proteínas |
US8586310B2 (en) | 2008-09-05 | 2013-11-19 | Washington University | Method for multiplexed nucleic acid patch polymerase chain reaction |
CA3075139C (fr) | 2008-09-23 | 2022-04-12 | Bio-Rad Laboratories, Inc. | Systeme de dosage base sur des gouttelettes |
US9156010B2 (en) | 2008-09-23 | 2015-10-13 | Bio-Rad Laboratories, Inc. | Droplet-based assay system |
US8699361B2 (en) | 2008-09-30 | 2014-04-15 | Qualcomm Incorporated | Out-of-synchronization handling method and apparatus |
US20100137143A1 (en) | 2008-10-22 | 2010-06-03 | Ion Torrent Systems Incorporated | Methods and apparatus for measuring analytes |
US8546128B2 (en) | 2008-10-22 | 2013-10-01 | Life Technologies Corporation | Fluidics system for sequential delivery of reagents |
US9528160B2 (en) | 2008-11-07 | 2016-12-27 | Adaptive Biotechnolgies Corp. | Rare clonotypes and uses thereof |
US8628927B2 (en) | 2008-11-07 | 2014-01-14 | Sequenta, Inc. | Monitoring health and disease status using clonotype profiles |
US9365901B2 (en) | 2008-11-07 | 2016-06-14 | Adaptive Biotechnologies Corp. | Monitoring immunoglobulin heavy chain evolution in B-cell acute lymphoblastic leukemia |
US20140234835A1 (en) * | 2008-11-07 | 2014-08-21 | Sequenta, Inc. | Rare clonotypes and uses thereof |
US9394567B2 (en) | 2008-11-07 | 2016-07-19 | Adaptive Biotechnologies Corporation | Detection and quantification of sample contamination in immune repertoire analysis |
US8691510B2 (en) | 2008-11-07 | 2014-04-08 | Sequenta, Inc. | Sequence analysis of complex amplicons |
CN104195227B (zh) | 2008-11-07 | 2017-04-12 | 适应生物技术公司 | 通过序列分析监测状况的方法 |
US8748103B2 (en) | 2008-11-07 | 2014-06-10 | Sequenta, Inc. | Monitoring health and disease status using clonotype profiles |
US9506119B2 (en) | 2008-11-07 | 2016-11-29 | Adaptive Biotechnologies Corp. | Method of sequence determination using sequence tags |
US20110105343A1 (en) | 2008-11-21 | 2011-05-05 | Emory University | Systems Biology Approach Predicts Immunogenicity of Vaccines |
US8367330B2 (en) | 2008-12-22 | 2013-02-05 | Quest Diagnostics Investments Incorporated | Methods for detecting TCR-gamma gene rearrangement |
CA2750155A1 (fr) | 2008-12-30 | 2010-07-08 | Centocor Ortho Biotech Inc. | Marqueurs seriques predisant la reponse clinique a des anticorps anti-tnf.alpha. chez les patients souffrant de spondylarthrite ankylosante |
EP2387627B1 (fr) | 2009-01-15 | 2016-03-30 | Adaptive Biotechnologies Corporation | Profilage d'immunité adaptative et méthodes de génération d'anticorps monoclonaux |
SG173048A1 (en) | 2009-01-20 | 2011-08-29 | Univ Leland Stanford Junior | Single cell gene expression for diagnosis, prognosis and identification of drug targets |
US20100323348A1 (en) | 2009-01-31 | 2010-12-23 | The Regents Of The University Of Colorado, A Body Corporate | Methods and Compositions for Using Error-Detecting and/or Error-Correcting Barcodes in Nucleic Acid Amplification Process |
US8574835B2 (en) | 2009-05-29 | 2013-11-05 | Life Technologies Corporation | Scaffolded nucleic acid polymer particles and methods of making and using |
US8673627B2 (en) | 2009-05-29 | 2014-03-18 | Life Technologies Corporation | Apparatus and methods for performing electrochemical reactions |
RU2539032C2 (ru) | 2009-06-25 | 2015-01-10 | Фред Хатчинсон Кансэр Рисёч Сентер | Способ измерения искусственного иммунитета |
US8497071B2 (en) | 2009-06-29 | 2013-07-30 | California Institute Of Technology | Isolation of unknown rearranged T-cell receptors from single cells |
AU2010273941A1 (en) | 2009-07-17 | 2012-02-09 | Brown University | Detection of short RNA sequences |
US8467973B2 (en) | 2009-07-28 | 2013-06-18 | Promising Future, Llc | Pairing processes for preparing alloreactive cytotoxic T cells |
CA2770143C (fr) | 2009-09-22 | 2015-11-03 | F. Hoffmann-La Roche Ag | Methode servant a determiner des haplotypes de kir associes a une maladie |
GB0917094D0 (en) | 2009-09-29 | 2009-11-11 | Ucl Biomedica Plc | T-cell receptor |
US9043160B1 (en) | 2009-11-09 | 2015-05-26 | Sequenta, Inc. | Method of determining clonotypes and clonotype profiles |
US9315857B2 (en) | 2009-12-15 | 2016-04-19 | Cellular Research, Inc. | Digital counting of individual molecules by stochastic attachment of diverse label-tags |
US8835358B2 (en) | 2009-12-15 | 2014-09-16 | Cellular Research, Inc. | Digital counting of individual molecules by stochastic attachment of diverse labels |
US8545248B2 (en) | 2010-01-07 | 2013-10-01 | Life Technologies Corporation | System to control fluid flow based on a leak detected by a sensor |
KR101323827B1 (ko) | 2010-01-08 | 2013-10-31 | 키스트 유럽 에프게엠베하 | 강직성척추염 진단용 프라이머 및 이를 이용한 강직성 척추염 진단 방법 |
GB201000375D0 (en) | 2010-01-09 | 2010-02-24 | Univ Cardiff | T Cell clonotypes |
WO2011106738A2 (fr) | 2010-02-25 | 2011-09-01 | Fred Hutchinson Cancer Research Center | Utilisation de clonotypes tcr en tant que biomarqueurs de maladie |
EP2367000A1 (fr) | 2010-03-04 | 2011-09-21 | Charité Universitätsmedizin Berlin | Analyse à haut rendement des répertoires de récepteur de lymphocyte T |
SG185128A1 (en) | 2010-05-06 | 2012-12-28 | Sequenta Inc | Monitoring health and disease status using clonotype profiles |
EP2566984B1 (fr) | 2010-05-07 | 2019-04-03 | The Board of Trustees of the Leland Stanford Junior University | Mesure et comparaison de la diversité immunitaire par séquençage à haut débit |
US20130123120A1 (en) | 2010-05-18 | 2013-05-16 | Natera, Inc. | Highly Multiplex PCR Methods and Compositions |
AU2011226792A1 (en) | 2010-06-11 | 2012-01-12 | Life Technologies Corporation | Alternative nucleotide flows in sequencing-by-synthesis methods |
WO2012012703A2 (fr) | 2010-07-23 | 2012-01-26 | Esoterix Genetic Laboratories, Llc | Identification de régions génomiques fœtales ou maternelles différentiellement représentées et ses utilisations |
EP2601521B1 (fr) | 2010-08-06 | 2018-05-02 | Ludwig-Maximilians-Universität München | Identification d'antigènes cibles de lymphocytes t |
WO2012027503A2 (fr) | 2010-08-24 | 2012-03-01 | Fred Hutchinson Cancer Research Center | Procédé de mesure de l'immunité adaptative |
LT2618835T (lt) | 2010-09-20 | 2017-10-10 | Biontech Cell & Gene Therapies Gmbh | Antigenui specifiniai t ląstelių receptoriai ir t ląstelių epitopai |
WO2012038839A2 (fr) | 2010-09-21 | 2012-03-29 | Population Genetics Technologies Ltd. | Niveau de confiance accru d'appels d'allèles par un comptage moléculaire |
EP3447155A1 (fr) | 2010-09-30 | 2019-02-27 | Raindance Technologies, Inc. | Dosages en sandwich dans des gouttelettes |
GB2497912B (en) | 2010-10-08 | 2014-06-04 | Harvard College | High-throughput single cell barcoding |
DK2625295T3 (da) | 2010-10-08 | 2019-06-11 | Harvard College | High-throughput-immunsekvensering |
EP2633069B1 (fr) | 2010-10-26 | 2015-07-01 | Illumina, Inc. | Procédés de séquençage |
AU2011323107B2 (en) | 2010-11-05 | 2015-09-10 | Illumina, Inc. | Linking sequence reads using paired code tags |
US9193997B2 (en) | 2010-12-15 | 2015-11-24 | The Board Of Trustees Of The Leland Stanford Junior University | Measuring and monitoring of cell clonality |
WO2012083225A2 (fr) | 2010-12-16 | 2012-06-21 | Gigagen, Inc. | Système et procédés pour l'analyse parallèle massive des acides nucléiques contenus dans des cellules individuelles |
WO2012118555A1 (fr) | 2010-12-29 | 2012-09-07 | Life Technologies Corporation | Signal de fond aligné dans le temps pour opérations de séquençage par synthèse |
EP3582224A1 (fr) | 2010-12-30 | 2019-12-18 | Life Technologies Corporation | Modèles pour analyser des données issues d'opérations de séquençage par synthèse |
DK2683736T3 (en) | 2011-03-09 | 2018-04-23 | Cell Signaling Technology Inc | METHODS AND REAGENTS FOR CREATING MONOCLONAL ANTIBODIES |
US8759036B2 (en) | 2011-03-21 | 2014-06-24 | Affymetrix, Inc. | Methods for synthesizing pools of probes |
EP2697397B1 (fr) | 2011-04-15 | 2017-04-05 | The Johns Hopkins University | Système de séquençage sûr |
KR102112205B1 (ko) | 2011-04-28 | 2020-06-12 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | 샘플과 연관된 폴리뉴클레오티드의 식별 |
US10738355B2 (en) | 2011-05-24 | 2020-08-11 | Tron-Translationale Onkologie An Der Universitätsmedizin Der Johannes Gutenberg-Universität Mainz Ggmbh | Individualized vaccines for cancer |
WO2013033721A1 (fr) | 2011-09-02 | 2013-03-07 | Atreca, Inc. | Code-barres adn pour le séquençage multiplex |
US20140356339A1 (en) | 2011-09-09 | 2014-12-04 | Sequenta Inc. | Sequence-based measures of immune response |
US10385475B2 (en) | 2011-09-12 | 2019-08-20 | Adaptive Biotechnologies Corp. | Random array sequencing of low-complexity libraries |
WO2013055595A1 (fr) | 2011-10-11 | 2013-04-18 | Sequenta, Inc. | Détermination de la sensibilité de patients atteints d'une maladie auto-immune au traitement sous armm |
AU2012325791B2 (en) | 2011-10-21 | 2018-04-05 | Adaptive Biotechnologies Corporation | Quantification of adaptive immune cell genomes in a complex mixture of cells |
US20130137108A1 (en) | 2011-10-25 | 2013-05-30 | Anubhav Tripathi | Magnetic bead separation apparatus and method |
WO2013066726A1 (fr) | 2011-11-04 | 2013-05-10 | Sequenta, Inc. | Clonotypes de récepteurs de l'antigène des lymphocytes t partagés entre des patients atteints de spondylarthrite ankylosante |
WO2013085855A1 (fr) | 2011-12-05 | 2013-06-13 | Sequenta, Inc. | Clonotypes utilisés en tant qu'étiquettes biométriques pour spécimens |
ES2683037T3 (es) | 2011-12-09 | 2018-09-24 | Adaptive Biotechnologies Corporation | Diagnóstico de tumores malignos linfoides y detección de enfermedad residual mínima |
EP2788507A4 (fr) | 2011-12-09 | 2015-07-08 | Sequenta Inc | Procédé de mesure de l'activation immunitaire |
US20150031553A1 (en) | 2011-12-13 | 2015-01-29 | Sequenta, Inc. | Method of measuring immune activation |
US9499865B2 (en) | 2011-12-13 | 2016-11-22 | Adaptive Biotechnologies Corp. | Detection and measurement of tissue-infiltrating lymphocytes |
US20140349883A1 (en) | 2011-12-20 | 2014-11-27 | Sequenta, Inc. | Monitoring transformation of follicular lymphoma to diffuse large b-cell lymphoma by immune repertoire analysis |
WO2013112655A1 (fr) | 2012-01-24 | 2013-08-01 | Gigagen, Inc. | Procédé de correction de biais dans l'amplification multiplexée |
EP3882633A1 (fr) | 2012-02-09 | 2021-09-22 | MeMed Diagnostics Ltd. | Signatures et déterminants pour diagnostiquer des infections et leurs procédés d'utilisation |
US10011871B2 (en) | 2012-02-17 | 2018-07-03 | Fred Hutchinson Cancer Research Center | Compositions and methods for accurately identifying mutations |
EP2820174B1 (fr) | 2012-02-27 | 2019-12-25 | The University of North Carolina at Chapel Hill | Procédés et utilisations d'étiquettes moléculaires |
WO2013131074A1 (fr) | 2012-03-02 | 2013-09-06 | Diogenix, Inc. | Procédés et réactifs pour évaluer une maladie auto-immune et déterminer un répertoire d'anticorps |
US20150038346A1 (en) | 2012-03-05 | 2015-02-05 | Sequenta, Inc. | Monitoring immune responsiveness to cancer vaccination |
WO2013134302A1 (fr) | 2012-03-05 | 2013-09-12 | Sequenta, Inc. | Contrôle de la réponse immunitaire à la vaccination contre le cancer |
JP6302847B2 (ja) | 2012-03-05 | 2018-03-28 | アダプティヴ バイオテクノロジーズ コーポレーション | 頻度が一致したサブユニットからの、対をなす免疫受容体鎖の決定 |
WO2013138510A1 (fr) | 2012-03-13 | 2013-09-19 | Patel Abhijit Ajit | Mesure des variants d'acide nucléique au moyen du séquençage hautement multiplexé, à très haut débit et à suppression d'erreur |
WO2013155119A1 (fr) | 2012-04-13 | 2013-10-17 | Sequenta, Inc. | Détection et quantification de la contamination d'échantillons dans une analyse de répertoire immunologique |
WO2013158936A1 (fr) | 2012-04-20 | 2013-10-24 | Sequenta, Inc | Surveillance de l'évolution des chaînes lourdes d'immunoglobuline dans le cas d'une leucémie lymphoblastique aiguë dans le lymphocyte b |
EP2841601B1 (fr) | 2012-04-24 | 2019-03-06 | Gen9, Inc. | Procédés de tri d'acides nucléiques et de clonage in vitro multiplex préparatoire |
JP5756247B1 (ja) | 2012-05-08 | 2015-07-29 | アダプティブ バイオテクノロジーズ コーポレイション | マルチプレックスpcr反応における増幅バイアスを測定し校正する組成物及び方法 |
WO2013181428A2 (fr) | 2012-05-31 | 2013-12-05 | Sequenta, Inc. | Prédiction de rechute de patients atteints de leucémie lymphocytaire chronique traités par transplantation de cellules souches allogéniques |
US20130324422A1 (en) | 2012-06-04 | 2013-12-05 | Sequenta, Inc. | Detecting disease-correlated clonotypes from fixed samples |
SG11201407888RA (en) | 2012-06-11 | 2014-12-30 | Sequenta Inc | Method of sequence determination using sequence tags |
EP2861761A1 (fr) | 2012-06-15 | 2015-04-22 | Adaptive Biotechnologies Corporation | Gènes de récepteur immunitaire adaptatif réorganisés à marquage unique dans un ensemble génique complexe |
US20150154352A1 (en) | 2012-06-21 | 2015-06-04 | Gigagen, Inc. | System and Methods for Genetic Analysis of Mixed Cell Populations |
US20150247182A1 (en) | 2012-07-24 | 2015-09-03 | Adaptive Biotechnologies Corp. | Single cell analysis using sequence tags |
JP2015524282A (ja) | 2012-08-10 | 2015-08-24 | シーケンタ インコーポレイテッド | 配列タグを用いた高感度突然変異検出 |
US20140065629A1 (en) | 2012-08-29 | 2014-03-06 | Israel Barken | Methods of treating diseases |
DE112013004650T5 (de) | 2012-09-24 | 2015-06-18 | Cb Biotechnologies, Inc. | Multiplexpyrosequenzierung unter Verwendung nichtinterferierender, rauschbeendender Polynukleotididentifikationstags |
AU2013331212A1 (en) | 2012-10-19 | 2015-05-07 | Adaptive Biotechnologies Corp. | Monitoring clonotypes of plasma cell proliferative disorders in peripheral blood |
AU2013331135A1 (en) | 2012-10-19 | 2015-05-07 | Adaptive Biotechnologies Corp. | Monitoring diffuse large B-cell lymphoma from peripheral blood samples |
WO2014066184A1 (fr) | 2012-10-22 | 2014-05-01 | Sequenta, Inc. | Surveillance de clonotypes de lymphome à cellules du manteau dans le sang périphérique après immunotransplant |
JP6513035B2 (ja) | 2013-02-22 | 2019-05-15 | アダプティヴ バイオテクノロジーズ コーポレーション | 希少クロノタイプおよびその用途 |
US20140255944A1 (en) | 2013-03-08 | 2014-09-11 | Sequenta, Inc. | Monitoring treatment-resistant clones in lymphoid and myeloid neoplasms by relative levels of evolved clonotypes |
US20140255929A1 (en) | 2013-03-11 | 2014-09-11 | Sequenta, Inc. | Mosaic tags for labeling templates in large-scale amplifications |
JP6431895B2 (ja) | 2013-03-15 | 2018-12-05 | アダプティブ バイオテクノロジーズ コーポレイション | 複合遺伝子セットにおいてユニークにタグ付けされた再構成された適応免疫受容体遺伝子 |
US9708657B2 (en) | 2013-07-01 | 2017-07-18 | Adaptive Biotechnologies Corp. | Method for generating clonotype profiles using sequence tags |
US20160186260A1 (en) | 2013-07-26 | 2016-06-30 | Sequenta, Llc | Cancer vaccination with antigen evolution |
AU2014337063A1 (en) | 2013-10-18 | 2016-05-19 | Adaptive Biotechnologies Corp. | Predicting patient responsiveness to immune checkpoint inhibitors |
AU2015204569A1 (en) | 2014-01-10 | 2016-07-21 | Adaptive Biotechnologies Corp. | Methods for defining and predicting immune response to allograft |
US20150218656A1 (en) | 2014-02-03 | 2015-08-06 | Adaptive Biotechnologies Corp. | Methods for detection and diagnosis of a lymphoid malignancy using high throughput sequencing |
WO2015134787A2 (fr) | 2014-03-05 | 2015-09-11 | Adaptive Biotechnologies Corporation | Procédés dans lesquels on utilise des molécules synthétiques contenant des randomères |
US10066265B2 (en) | 2014-04-01 | 2018-09-04 | Adaptive Biotechnologies Corp. | Determining antigen-specific t-cells |
EP3132059B1 (fr) | 2014-04-17 | 2020-01-08 | Adaptive Biotechnologies Corporation | Quantification de génomes de cellules de l'immunité acquise dans un mélange complexe de cellules |
AU2015339191A1 (en) | 2014-10-29 | 2017-05-18 | Adaptive Biotechnologies Corp. | Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from many samples |
US10246701B2 (en) | 2014-11-14 | 2019-04-02 | Adaptive Biotechnologies Corp. | Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture |
WO2016138122A1 (fr) | 2015-02-24 | 2016-09-01 | Adaptive Biotechnologies Corp. | Méthodes pour le diagnostic d'une maladie infectieuse et la détermination du statut hla à l'aide du séquençage du répertoire immunitaire |
CA2979726A1 (fr) | 2015-04-01 | 2016-10-06 | Adaptive Biotechnologies Corp. | Procede d'identification des recepteurs de lymphocytes t specifiques a compatibilite humaine pour une cible antigenique |
-
2016
- 2016-04-01 CA CA2979726A patent/CA2979726A1/fr active Pending
- 2016-04-01 EP EP16774304.6A patent/EP3277294B1/fr active Active
- 2016-04-01 WO PCT/US2016/025535 patent/WO2016161273A1/fr active Application Filing
- 2016-04-01 US US15/563,365 patent/US11041202B2/en active Active
- 2016-04-01 AU AU2016242967A patent/AU2016242967B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP3277294C0 (fr) | 2024-05-15 |
EP3277294A1 (fr) | 2018-02-07 |
AU2016242967A1 (en) | 2017-09-28 |
EP3277294A4 (fr) | 2018-11-14 |
EP3277294B1 (fr) | 2024-05-15 |
US11041202B2 (en) | 2021-06-22 |
WO2016161273A1 (fr) | 2016-10-06 |
AU2016242967B2 (en) | 2021-07-01 |
US20180080078A1 (en) | 2018-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3277294B1 (fr) | Procédé d'identification des récepteurs de lymphocytes t spécifiques à compatibilité humaine pour une cible antigénique | |
US10465243B2 (en) | System and methods for massively parallel analysis of nucleic acids in single cells | |
JP6302847B2 (ja) | 頻度が一致したサブユニットからの、対をなす免疫受容体鎖の決定 | |
EP3212790B1 (fr) | Détection simultanée hautement multiplexée d'acides nucléiques codant pour des hétérodimères de récepteurs de l'immunité adaptative appariés à partir de nombreux échantillons | |
EP3126522B1 (fr) | Détermination de lymphocytes t et de lymphocytes b spécifiques à un antigène | |
JP6085249B2 (ja) | 複雑なアンプリコンの配列解析 | |
JP6431895B2 (ja) | 複合遺伝子セットにおいてユニークにタグ付けされた再構成された適応免疫受容体遺伝子 | |
JP6343563B2 (ja) | 組織浸潤リンパ球の検出および測定方法 | |
JP2015532123A (ja) | 免疫移植後の末梢血におけるマントル細胞リンパ腫のクローン型のモニタリング | |
JP2015535178A (ja) | 末梢血における形質細胞増殖障害のクロノタイプのモニタリング | |
WO2013188831A1 (fr) | Gènes de récepteur immunitaire adaptatif réorganisés à marquage unique dans un ensemble génique complexe | |
JP2015501644A (ja) | 免疫活性化を測定する方法 | |
JP2015519081A (ja) | 配列タグを用いた配列決定法 | |
CN112375816A (zh) | 用序列标签进行大规模生物分子分析 | |
WO2013036459A2 (fr) | Mesure d'une réponse immunitaire basée sur les séquences | |
JP2015534806A (ja) | 末梢血試料によるびまん性大細胞型b細胞性リンパ腫のモニタリング関連出願の相互参照本出願は、2012年10月19日出願の米国特許仮出願第61/716,270号の利益を主張するものであり、当該出願は参照により本明細書にその全体が組み込まれる。 | |
JP2015504661A (ja) | 免疫レパートリー解析による、濾胞性リンパ腫からびまん性大細胞型b細胞リンパ腫への形質転換のモニタリング | |
Wang et al. | A comprehensive analysis of the T and B lymphocytes repertoire shaped by HIV vaccines | |
WO2019183582A1 (fr) | Surveillance du répertoire immun | |
JP2023508991A (ja) | 核酸配列分析方法 | |
US11254980B1 (en) | Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements | |
WO2021003114A2 (fr) | Kit et procédé d'analyse de lymphocytes t uniques | |
Tu | Recovery of T cell receptor variable sequences from 3'barcoded single-cell RNA sequencing libraries | |
WO2023122237A1 (fr) | Kit et procédé d'analyse de récepteurs de lymphocytes t à partir de lymphocytes t individuels |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20210308 |
|
EEER | Examination request |
Effective date: 20210308 |
|
EEER | Examination request |
Effective date: 20210308 |
|
EEER | Examination request |
Effective date: 20210308 |
|
EEER | Examination request |
Effective date: 20210308 |
|
EEER | Examination request |
Effective date: 20210308 |
|
EEER | Examination request |
Effective date: 20210308 |
|
EEER | Examination request |
Effective date: 20210308 |